BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Sunday, May 5, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 15, 2012
View Archived Issues
Peptide inhibitor nanoparticles reduce beta-amyloid aggregation in preclinical study
Read More
NME protects human bone marrow progenitor cells against radiation
Read More
Endocyte to file conditional MAAs in E.U. for anticancer therapeutic and imaging agent
Read More
Cell>Point receives SPA agreement from FDA for imaging agent
Read More
HIV peptide-loaded dendritic cells evaluated in DALIA trial
Read More
Alkermes Pharma Ireland withdraws megestrol MAA
Read More
Oncothyreon starts phase I ONT-10 cancer vaccine trial
Read More
BioFocus, Argenta and AstraZeneca enter new research agreement
Read More
Okairos launches NIH-funded phase I/II trial of HCV vaccine
Read More
Epizyme achieves preclinical milestone in mixed-lineage leukemia
Read More
Phase II program for heart failure to proceed
Read More
Threshold Pharmaceuticals treats first patient in multiple myeloma study
Read More
Millennium Pharmaceuticals designs novel PI3K and mTOR inhibitors
Read More
FDA approves first effervescent osteoporosis drug
Read More
New metabotropic glutamate mGlu2 receptor antagonists developed
Read More
New apoptosis inducers divulged
Read More
Scientists from Varinel discover novel iron chelators
Read More
Domain Therapeutics announces new funding for schizophrenia project
Read More
Intercell kicks off phase II/III study of vaccine candidate
Read More
Foamix product demonstrates efficacy in phase II trial in impetigo
Read More
Novel potential hepatitis C therapies identified at Bristol-Myers Squibb
Read More
Boehringer Ingelheim patents new bradykinin B1 receptor antagonists
Read More
Novel mineralocorticoid receptor antagonists presented by KBP BioSciences
Read More
Amgen reports new myostatin-binding antibodies
Read More
Shire withdraws BLA for Fabry's disease therapy
Read More
First oral contraceptive for heavy menstrual bleeding approved in U.S.
Read More